IBDEI1KV ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28006,0)
 ;;=163.9^^162^1791^37
 ;;^UTILITY(U,$J,358.3,28006,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28006,1,4,0)
 ;;=4^163.9
 ;;^UTILITY(U,$J,358.3,28006,1,5,0)
 ;;=5^CA of Pleural Cavity
 ;;^UTILITY(U,$J,358.3,28006,2)
 ;;=CA Pleural Cavity^267140
 ;;^UTILITY(U,$J,358.3,28007,0)
 ;;=141.9^^162^1791^45
 ;;^UTILITY(U,$J,358.3,28007,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28007,1,4,0)
 ;;=4^141.9
 ;;^UTILITY(U,$J,358.3,28007,1,5,0)
 ;;=5^CA of Tongue
 ;;^UTILITY(U,$J,358.3,28007,2)
 ;;=CA Tongue^266995
 ;;^UTILITY(U,$J,358.3,28008,0)
 ;;=188.9^^162^1791^20
 ;;^UTILITY(U,$J,358.3,28008,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28008,1,4,0)
 ;;=4^188.9
 ;;^UTILITY(U,$J,358.3,28008,1,5,0)
 ;;=5^CA of Bladder
 ;;^UTILITY(U,$J,358.3,28008,2)
 ;;=Bladder CA^267253
 ;;^UTILITY(U,$J,358.3,28009,0)
 ;;=191.9^^162^1791^22
 ;;^UTILITY(U,$J,358.3,28009,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28009,1,4,0)
 ;;=4^191.9
 ;;^UTILITY(U,$J,358.3,28009,1,5,0)
 ;;=5^CA of Brain
 ;;^UTILITY(U,$J,358.3,28009,2)
 ;;=Brain CA^267279
 ;;^UTILITY(U,$J,358.3,28010,0)
 ;;=174.9^^162^1791^23
 ;;^UTILITY(U,$J,358.3,28010,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28010,1,4,0)
 ;;=4^174.9
 ;;^UTILITY(U,$J,358.3,28010,1,5,0)
 ;;=5^CA of Breast
 ;;^UTILITY(U,$J,358.3,28010,2)
 ;;=Breast CA^267202
 ;;^UTILITY(U,$J,358.3,28011,0)
 ;;=176.9^^162^1791^85
 ;;^UTILITY(U,$J,358.3,28011,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28011,1,4,0)
 ;;=4^176.9
 ;;^UTILITY(U,$J,358.3,28011,1,5,0)
 ;;=5^Kaposi's Sarcoma
 ;;^UTILITY(U,$J,358.3,28011,2)
 ;;=Kaposi's Sarcoma^107993
 ;;^UTILITY(U,$J,358.3,28012,0)
 ;;=172.9^^162^1791^92
 ;;^UTILITY(U,$J,358.3,28012,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28012,1,4,0)
 ;;=4^172.9
 ;;^UTILITY(U,$J,358.3,28012,1,5,0)
 ;;=5^Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,28012,2)
 ;;=^75462
 ;;^UTILITY(U,$J,358.3,28013,0)
 ;;=185.^^162^1791^38
 ;;^UTILITY(U,$J,358.3,28013,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28013,1,4,0)
 ;;=4^185.
 ;;^UTILITY(U,$J,358.3,28013,1,5,0)
 ;;=5^CA of Prostate
 ;;^UTILITY(U,$J,358.3,28013,2)
 ;;=Prostate CA^99481
 ;;^UTILITY(U,$J,358.3,28014,0)
 ;;=189.0^^162^1791^40
 ;;^UTILITY(U,$J,358.3,28014,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28014,1,4,0)
 ;;=4^189.0
 ;;^UTILITY(U,$J,358.3,28014,1,5,0)
 ;;=5^CA of Renal
 ;;^UTILITY(U,$J,358.3,28014,2)
 ;;=Renal Cancer^73523
 ;;^UTILITY(U,$J,358.3,28015,0)
 ;;=189.1^^162^1791^41
 ;;^UTILITY(U,$J,358.3,28015,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28015,1,4,0)
 ;;=4^189.1
 ;;^UTILITY(U,$J,358.3,28015,1,5,0)
 ;;=5^CA of Renal Pelvis
 ;;^UTILITY(U,$J,358.3,28015,2)
 ;;=   ^267264
 ;;^UTILITY(U,$J,358.3,28016,0)
 ;;=171.9^^162^1791^111
 ;;^UTILITY(U,$J,358.3,28016,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28016,1,4,0)
 ;;=4^171.9
 ;;^UTILITY(U,$J,358.3,28016,1,5,0)
 ;;=5^Soft Tissue Sarcoma
 ;;^UTILITY(U,$J,358.3,28016,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,28017,0)
 ;;=186.9^^162^1791^44
 ;;^UTILITY(U,$J,358.3,28017,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28017,1,4,0)
 ;;=4^186.9
 ;;^UTILITY(U,$J,358.3,28017,1,5,0)
 ;;=5^CA of Testis
 ;;^UTILITY(U,$J,358.3,28017,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,28018,0)
 ;;=198.7^^162^1791^98
 ;;^UTILITY(U,$J,358.3,28018,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28018,1,4,0)
 ;;=4^198.7
 ;;^UTILITY(U,$J,358.3,28018,1,5,0)
 ;;=5^Mets to Adrenal Gland
 ;;^UTILITY(U,$J,358.3,28018,2)
 ;;=^267337
 ;;^UTILITY(U,$J,358.3,28019,0)
 ;;=198.5^^162^1791^99
 ;;^UTILITY(U,$J,358.3,28019,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28019,1,4,0)
 ;;=4^198.5
 ;;
 ;;$END ROU IBDEI1KV
